Lyrus is a focused formulation development organisation hence it has partnered with some long term associates and their infrastructure for Exhibit and Commercial manufacturing
Lyrus has in-house capability for pilot scale manufacturing for all its formulation development initiatives. As Lyrus is committed to provide end-to-end solutions to its clients, it has secured reliable contracts with well accredited manufacturers. All our contracted manufacturing sites are either approved by MHRA/EU GMP/FDA/PICs/TGA and/or country specific competent Authorities. We also have strategic manufacturing alliances globally to address market or dosage forms specific requirements.
This arrangement provides Lyrus with very distinct advantages
- Undivided attention to its core business of “Formulation Development”
- Portability – As Lyrus is developing many niche molecules, it becomes important to go beyond capabilities available in India from either quality, convenience or economy perspective.